These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 32647340)
1. Increased S1P induces S1PR2 internalization to blunt the sensitivity of colorectal cancer to 5-fluorouracil via promoting intracellular uracil generation. Zhang YH; Cui SX; Wan SB; Wu SH; Qu XJ Acta Pharmacol Sin; 2021 Mar; 42(3):460-469. PubMed ID: 32647340 [TBL] [Abstract][Full Text] [Related]
2. S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer. Zhang YH; Luo DD; Wan SB; Qu XJ Pharmacol Res; 2020 May; 155():104717. PubMed ID: 32088343 [TBL] [Abstract][Full Text] [Related]
3. Novel 5-fluorouracil sensitizers for colorectal cancer therapy: Design and synthesis of S1P receptor 2 (S1PR2) antagonists. Luo D; Guo Z; Zhao X; Wu L; Liu X; Zhang Y; Zhang Y; Deng Z; Qu X; Cui S; Wan S Eur J Med Chem; 2022 Jan; 227():113923. PubMed ID: 34688013 [TBL] [Abstract][Full Text] [Related]
4. ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield. Ou J; Peng Y; Yang W; Zhang Y; Hao J; Li F; Chen Y; Zhao Y; Xie X; Wu S; Zha L; Luo X; Xie G; Wang L; Sun W; Zhou Q; Li J; Liang H Nat Commun; 2019 Mar; 10(1):1078. PubMed ID: 30842415 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer. Luo D; Zhang Y; Yang S; Tian X; Lv Y; Guo Z; Liu X; Han G; Liu S; Wang W; Cui S; Qu X; Wan S Eur J Med Chem; 2021 Dec; 225():113775. PubMed ID: 34411894 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of JTE-013 derivatives as novel potent S1PR2 antagonists for recovering the sensitivity of colorectal cancer to 5-fluorouracil. Guo Z; Zhang S; Liu X; Zhao G; Zhang Y; Luo D; Zhao X; Xu X; Qu X; Li L; Wan S; Cui S Bioorg Chem; 2023 Feb; 131():106318. PubMed ID: 36527992 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury. Zhao X; Yang L; Chang N; Hou L; Zhou X; Dong C; Liu F; Yang L; Li L Cell Immunol; 2021 Jan; 359():104243. PubMed ID: 33197723 [TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate/S1PR2-mediated signaling triggers Smad1/5/8 phosphorylation and thereby induces Runx2 expression in osteoblasts. Higashi K; Matsuzaki E; Hashimoto Y; Takahashi-Yanaga F; Takano A; Anan H; Hirata M; Nishimura F Bone; 2016 Dec; 93():1-11. PubMed ID: 27612439 [TBL] [Abstract][Full Text] [Related]
9. The Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis in Intestinal Epithelial Cells Regulates Intestinal Barrier Function During Intestinal Epithelial Cells-CD4+T-Cell Interactions. Chen T; Lin R; Jin S; Chen R; Xue H; Ye H; Huang Z Cell Physiol Biochem; 2018; 48(3):1188-1200. PubMed ID: 30045015 [TBL] [Abstract][Full Text] [Related]
10. Alteration of sphingosine-1-phosphate with aging induces contractile dysfunction of colonic smooth muscle cells via Ca Shen X; Zhang L; Jiang L; Xiong W; Tang Y; Lin L; Yu T Neurogastroenterol Motil; 2021 May; 33(5):e14052. PubMed ID: 33452855 [TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1 phosphate promotes intestinal epithelial cell proliferation via S1PR2. Chen T; Huang Z; Liu R; Yang J; Hylemon PB; Zhou H Front Biosci (Landmark Ed); 2017 Jan; 22(4):596-608. PubMed ID: 27814635 [TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia-Triggered Sphingosine-1-Phosphate and Sphingosine-1-Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization. Hu Y; Yang C; Shen G; Yang S; Cheng X; Cheng F; Rao J; Wang X Liver Transpl; 2019 Jul; 25(7):1074-1090. PubMed ID: 30972941 [TBL] [Abstract][Full Text] [Related]
14. NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate/S1P receptor 2/Gα Hou L; Zhang Z; Yang L; Chang N; Zhao X; Zhou X; Yang L; Li L J Mol Med (Berl); 2021 Feb; 99(2):273-288. PubMed ID: 33388881 [TBL] [Abstract][Full Text] [Related]
15. Targeting the SPHK1/S1P/S1PR2 axis ameliorates GH-secreted pituitary adenoma progression. Sun H; Hu B; Wu C; Jiang T Eur J Clin Invest; 2024 Mar; 54(3):e14117. PubMed ID: 37888843 [TBL] [Abstract][Full Text] [Related]
16. Association between sphingosine-1-phosphate-induced signal transduction via mitogen-activated protein kinase pathways and keloid formation. Jung SH; Song YK; Chung H; Ko HM; Lee SH; Jo DI; Kim B; Lee DH; Kim SH Arch Dermatol Res; 2019 Nov; 311(9):711-719. PubMed ID: 31385019 [TBL] [Abstract][Full Text] [Related]
17. Differential activation of receptors and signal pathways upon stimulation by different doses of sphingosine-1-phosphate in endothelial cells. Li Q; Chen B; Zeng C; Fan A; Yuan Y; Guo X; Huang X; Huang Q Exp Physiol; 2015 Jan; 100(1):95-107. PubMed ID: 25557733 [TBL] [Abstract][Full Text] [Related]
18. Expression of sphingosine-1-phosphate receptor 2 is correlated with migration and invasion of human colon cancer cells: A preliminary clinical study. Yan J; Chen Y; Wu Q; Shao L; Zhou X Oncol Lett; 2022 Jul; 24(1):241. PubMed ID: 35720474 [TBL] [Abstract][Full Text] [Related]
20. The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice. Wang Y; Aoki H; Yang J; Peng K; Liu R; Li X; Qiang X; Sun L; Gurley EC; Lai G; Zhang L; Liang G; Nagahashi M; Takabe K; Pandak WM; Hylemon PB; Zhou H Hepatology; 2017 Jun; 65(6):2005-2018. PubMed ID: 28120434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]